Predictions
Hexo Corp.
Start price
Target price
Perf. (%)
€22.26
13.11.21
13.11.21
€28.00
13.11.22
13.11.22
-88.09%
14.11.22
14.11.22
Higher risks for its business
Callon Petroleum Co.
Start price
Target price
Perf. (%)
€56.00
13.11.21
13.11.21
-
13.11.22
13.11.22
-19.78%
15.09.22
15.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management
Future proof or reliable business model
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€0.79
13.11.21
13.11.21
€0.000
13.11.22
13.11.22
-26.11%
27.11.21
27.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€7.37
13.11.21
13.11.21
-
13.11.22
13.11.22
-79.10%
14.11.22
14.11.22
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Innovative
Top 10 in its market
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.80
13.11.21
13.11.21
€50.00
31.12.23
31.12.23
11.71%
29.06.22
29.06.22
Could be very worthwhile Investment >20% year
Altamira Therapeutics Ltd.
Start price
Target price
Perf. (%)
€2.40
12.11.21
12.11.21
-
12.11.22
12.11.22
-20.42%
14.11.21
14.11.21
Risky Investment
Catalyst Biosciences Inc
Start price
Target price
Perf. (%)
€0.89
12.11.21
12.11.21
-
12.11.22
12.11.22
-14.69%
15.11.21
15.11.21
Risky Investment
Novavax Inc.
Start price
Target price
Perf. (%)
€145.98
11.11.21
11.11.21
€75.00
11.11.22
11.11.22
-63.74%
11.04.22
11.04.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Baozun Inc ADR
Start price
Target price
Perf. (%)
€15.50
11.11.21
11.11.21
€18.00
11.11.22
11.11.22
-24.19%
05.12.21
05.12.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Hecla Mining Corp.
Start price
Target price
Perf. (%)
€5.50
11.11.21
11.11.21
€6.00
11.11.22
11.11.22
-8.36%
27.11.21
27.11.21
Very low/no dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Nanobiotix
Start price
Target price
Perf. (%)
€8.51
11.11.21
11.11.21
€10.00
11.11.22
11.11.22
-53.17%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.95
11.11.21
11.11.21
€30.00
11.11.22
11.11.22
-21.68%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€2.19
11.11.21
11.11.21
-
11.11.22
11.11.22
2.28%
17.11.21
17.11.21
Could be worthwhile Investment >10% per year
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€70.55
11.11.21
11.11.21
€75.00
11.11.22
11.11.22
-17.72%
21.02.22
21.02.22
Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Kulicke & Soffa Industries Inc.
Start price
Target price
Perf. (%)
€48.20
11.11.21
11.11.21
-
11.11.22
11.11.22
2.90%
12.11.21
12.11.21
Cresud S.A.C.I.F. y A. ADR
Start price
Target price
Perf. (%)
€4.48
11.11.21
11.11.21
-
11.11.22
11.11.22
3.13%
12.11.21
12.11.21
Gruppo Mutuionline S.p.A.
Start price
Target price
Perf. (%)
€42.15
11.11.21
11.11.21
-
11.11.22
11.11.22
1.90%
12.11.21
12.11.21